Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders
dc.contributor.author | Regan, Julie | |
dc.contributor.author | Walshe, Margaret | |
dc.contributor.author | Murphy, Anne | |
dc.contributor.author | McMahon, Barry P. | |
dc.contributor.author | Coughlan, Tara | |
dc.date.accessioned | 2012-09-17T08:38:54Z | |
dc.date.available | 2012-09-17T08:38:54Z | |
dc.date.issued | 2012-07-11 | |
dc.identifier.citation | Regan J, Walshe M, Murphy A, McMahon BP, Coughlan T. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD009968. DOI: 10.1002/14651858.CD009968. | en_GB |
dc.identifier.uri | http://hdl.handle.net/10147/244213 | |
dc.description | This is the protocol for a review and there is no abstract. The objectives are as follows: To establish the efficacy and safety of botulinum toxin aimed at improving UOS dysfunction in people with non progressive and progressive neurological disease. To provide the best evidence to inform clinical practice. To assist with future research planning. | en_GB |
dc.publisher | John Wiley | en_GB |
dc.relation.url | DOI: 10.1002/14651858.CD009968 | en_GB |
dc.relation.url | http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009968/abstract | en_GB |
dc.subject | Dysphagia | en_GB |
dc.subject | Botulinum Toxin | en_GB |
dc.subject | Deglutition Disorders | en_GB |
dc.subject | Esophageal Sphincter | en_GB |
dc.title | Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders | en_GB |
dc.type | Other | en |
dc.contributor.department | Tallaght Hospital ; Trinity College Dublin | en_GB |
dc.identifier.journal | The Cochrane Library | en_GB |